Correlation Between JM AB and Active Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JM AB and Active Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JM AB and Active Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JM AB and Active Biotech AB, you can compare the effects of market volatilities on JM AB and Active Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JM AB with a short position of Active Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of JM AB and Active Biotech.

Diversification Opportunities for JM AB and Active Biotech

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between JM AB and Active is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding JM AB and Active Biotech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Active Biotech AB and JM AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JM AB are associated (or correlated) with Active Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Active Biotech AB has no effect on the direction of JM AB i.e., JM AB and Active Biotech go up and down completely randomly.

Pair Corralation between JM AB and Active Biotech

Assuming the 90 days horizon JM AB is expected to under-perform the Active Biotech. But the stock apears to be less risky and, when comparing its historical volatility, JM AB is 5.96 times less risky than Active Biotech. The stock trades about -0.05 of its potential returns per unit of risk. The Active Biotech AB is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  9.00  in Active Biotech AB on April 22, 2025 and sell it today you would earn a total of  12.00  from holding Active Biotech AB or generate 133.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

JM AB  vs.  Active Biotech AB

 Performance 
       Timeline  
JM AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days JM AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, JM AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Active Biotech AB 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Active Biotech AB are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Active Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.

JM AB and Active Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JM AB and Active Biotech

The main advantage of trading using opposite JM AB and Active Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JM AB position performs unexpectedly, Active Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Active Biotech will offset losses from the drop in Active Biotech's long position.
The idea behind JM AB and Active Biotech AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences